In another gene therapy approach, the angiogenesis inhibitor endostatin and the potent immunogen green fluorescent protein (GFP) were delivered to murine neuroblastoma cells prior to inoculation of tumor cells into syngeneic immunocompetent mice [54]. The gene discussed is COL18A1; the disease is neoplasm.